BACKGROUND AND AIMS: Peutz-Jeghers syndrome (PJS) is a dominantly inherited disorder often caused by mutations in STK11. Time to onset of symptoms was characterised for a large collection of individuals with PJS who had been tested for STK11 mutations and genotype-phenotype correlations were evaluated. METHODS: We characterised mutations in 42 independent probands and also used a historical cohort design to study 51 individuals with Peutz-Jeghers syndrome who had completed self-administered questionnaires. RESULTS: Mutations were detected in 22/32 (69%) probands with PJS and 0/10 probands referred to rule out PJS. Real-time PCR analysis to quantitate DNA failed to detect any large deletions in PJS participants without STK11 mutations. The median time to onset for gastrointestinal symptoms or polypectomy was 13 years of age but showed a wide variability. Gastric polyps were frequent in PJS participants, with a median age at onset of 16 years. Individuals with missense mutations had a significantly later time to onset of first polypectomy (p = 0.04) and of other symptoms compared with those participants either with truncating mutations or no detectable mutation. CONCLUSION: STK11 mutation analysis should be restricted to individuals who meet PJS criteria or their close relatives. Direct sequencing of STK11 yields a high rate of point mutations in individuals who meet phenotypic PJS criteria. Individuals with missense mutations of STK11 typically had a later time to onset for PJS symptoms. The common occurrence of gastric polyps may facilitate chemopreventive studies for this disorder.
BACKGROUND AND AIMS: Peutz-Jeghers syndrome (PJS) is a dominantly inherited disorder often caused by mutations in STK11. Time to onset of symptoms was characterised for a large collection of individuals with PJS who had been tested for STK11 mutations and genotype-phenotype correlations were evaluated. METHODS: We characterised mutations in 42 independent probands and also used a historical cohort design to study 51 individuals with Peutz-Jeghers syndrome who had completed self-administered questionnaires. RESULTS: Mutations were detected in 22/32 (69%) probands with PJS and 0/10 probands referred to rule out PJS. Real-time PCR analysis to quantitate DNA failed to detect any large deletions in PJSparticipants without STK11 mutations. The median time to onset for gastrointestinal symptoms or polypectomy was 13 years of age but showed a wide variability. Gastric polyps were frequent in PJSparticipants, with a median age at onset of 16 years. Individuals with missense mutations had a significantly later time to onset of first polypectomy (p = 0.04) and of other symptoms compared with those participants either with truncating mutations or no detectable mutation. CONCLUSION:STK11 mutation analysis should be restricted to individuals who meet PJS criteria or their close relatives. Direct sequencing of STK11 yields a high rate of point mutations in individuals who meet phenotypic PJS criteria. Individuals with missense mutations of STK11 typically had a later time to onset for PJS symptoms. The common occurrence of gastric polyps may facilitate chemopreventive studies for this disorder.
Authors: G Steinbach; P M Lynch; R K Phillips; M H Wallace; E Hawk; G B Gordon; N Wakabayashi; B Saunders; Y Shen; T Fujimura; L K Su; B Levin; L Godio; S Patterson; M A Rodriguez-Bigas; S L Jester; K L King; M Schumacher; J Abbruzzese; R N DuBois; W N Hittelman; S Zimmerman; J W Sherman; G Kelloff Journal: N Engl J Med Date: 2000-06-29 Impact factor: 91.245
Authors: L A Boardman; F J Couch; L J Burgart; D Schwartz; R Berry; S K McDonnell; D J Schaid; L C Hartmann; J J Schroeder; C A Stratakis; S N Thibodeau Journal: Hum Mutat Date: 2000 Impact factor: 4.878
Authors: H S Choi; Y J Park; E G Youk; K A Yoon; J L Ku; N K Kim; S M Kim; Y J Kim; D J Moon; J S Min; C J Park; O S Bae; D H Yang; S H Jun; E S Chung; P M Jung; Y Whang; J G Park Journal: Int J Colorectal Dis Date: 2000-02 Impact factor: 2.571
Authors: A Ylikorkala; E Avizienyte; I P Tomlinson; M Tiainen; S Roth; A Loukola; A Hemminki; M Johansson; P Sistonen; D Markie; K Neale; R Phillips; P Zauber; T Twama; J Sampson; H Järvinen; T P Mäkelä; L A Aaltonen Journal: Hum Mol Genet Date: 1999-01 Impact factor: 6.150
Authors: H Mehenni; C Gehrig; J Nezu; A Oku; M Shimane; C Rossier; N Guex; J L Blouin; H S Scott; S E Antonarakis Journal: Am J Hum Genet Date: 1998-12 Impact factor: 11.025
Authors: K A Yoon; J L Ku; H S Choi; S C Heo; S Y Jeong; Y J Park; N K Kim; J C Kim; P M Jung; J G Park Journal: Br J Cancer Date: 2000-04 Impact factor: 7.640
Authors: Michael Kam; Jorge Massare; Steven Gallinger; Joseph Kinzie; Donald Weaver; John D Dingell; Susmita Esufali; Bharati Bapat; Martin Tobi Journal: Dig Dis Sci Date: 2006-08-22 Impact factor: 3.199
Authors: Sapna Syngal; Randall E Brand; James M Church; Francis M Giardiello; Heather L Hampel; Randall W Burt Journal: Am J Gastroenterol Date: 2015-02-03 Impact factor: 10.864
Authors: N C M Hearle; M F Rudd; W Lim; V Murday; A G Lim; R K Phillips; P W Lee; J O'donohue; P J Morrison; A Norman; S V Hodgson; A Lucassen; R S Houlston Journal: J Med Genet Date: 2006-04 Impact factor: 6.318
Authors: Chongjuan Wei; Christopher I Amos; Nianxiang Zhang; Jing Zhu; Xiaopei Wang; Marsha L Frazier Journal: Cancer Lett Date: 2009-01-14 Impact factor: 8.679
Authors: Michael F Wangler; Rishikesh Chavan; M John Hicks; Jed G Nuchtern; Madhuri Hegde; Sharon E Plon; Patrick A Thompson Journal: J Pediatr Hematol Oncol Date: 2013-05 Impact factor: 1.289